Wednesday, Jan 20, 2021
Focus on the big picture

Shanghai Henlius Biotech Working on Covid Treatment Drug

Bloomberg, 12 Jan 2021
Jan.12 -- Zhang Wenjie, chief executive officer of Shanghai Henlius Biotech Inc., a Chinese developer of biosimilar drugs, discusses the company's strategy and ...
Related Articles